Literature DB >> 15110532

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.

Joshua J Short1, Alexander V Pereboev, Yosuke Kawakami, Chenthamarakshan Vasu, Mark J Holterman, David T Curiel.   

Abstract

Most viruses exploit a variety of host cellular proteins as primary cellular attachment receptors in the context of successful execution of infection. Furthermore, many viral agents have evolved precise mechanisms to subvert host immune recognition to achieve persistence. Herein we present data indicating that adenovirus (Ad) serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. CD80 and CD86 are co-stimulatory molecules that are present on mature dendritic cells and B lymphocytes and are involved in stimulating T-lymphocyte activation. To our knowledge, this is one of the first demonstrations of a virus utilizing immunologic accessory molecules as a primary means of cellular entry. This finding suggests a mechanism whereby viral exploitation of these proteins as receptors may achieve both goals of cellular entry and evading the immune system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110532     DOI: 10.1016/j.virol.2004.02.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

1.  CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.

Authors:  Marko Marttila; David Persson; Dan Gustafsson; M Kathryn Liszewski; John P Atkinson; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 3.  Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.

Authors:  J Michael Mathis; Phoebe L Stewart; Zheng B Zhu; David T Curiel
Journal:  Clin Cancer Res       Date:  2006-05-01       Impact factor: 12.531

Review 4.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

5.  Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors.

Authors:  Joshua J Short; Chenthamarakshan Vasu; Mark J Holterman; David T Curiel; Alexander Pereboev
Journal:  Virus Res       Date:  2006-08-22       Impact factor: 3.303

Review 6.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

7.  Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design.

Authors:  Ijad Madisch; Soeren Hofmayer; Christian Moritz; Alexander Grintzalis; Jens Hainmueller; Patricia Pring-Akerblom; Albert Heim
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1.

Authors:  Sharmila Raman; Tien-Huei Hsu; Shanna L Ashley; Katherine R Spindler
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

10.  Dilated cardiomyopathy alters the expression patterns of CAR and other adenoviral receptors in human heart.

Authors:  Raine Toivonen; Mikko I Mäyränpää; Petri T Kovanen; Mikko Savontaus
Journal:  Histochem Cell Biol       Date:  2009-12-02       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.